Published in BMC Musculoskelet Disord on February 08, 2011
Inflammation in osteoarthritis. Curr Opin Rheumatol (2011) 2.72
Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure. Microb Ecol Health Dis (2012) 1.39
Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture. BMC Musculoskelet Disord (2013) 0.81
Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism. Arthritis Res Ther (2013) 0.77
Molecular basis of oxidative stress in gouty arthropathy. Clin Rheumatol (2015) 0.77
Acute cell viability and nitric oxide release in lateral menisci following closed-joint knee injury in a lapine model of post-traumatic osteoarthritis. BMC Musculoskelet Disord (2014) 0.76
Monosodium urate crystals induce oxidative stress in human synoviocytes. Arthritis Res Ther (2016) 0.75
Protective effects of Fructus sophorae extract on collagen-induced arthritis in BALB/c mice. Exp Ther Med (2016) 0.75
Noxa in rheumatic diseases: present understanding and future impact. Rheumatology (Oxford) (2013) 0.75
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
Osteoarthritis. J Cell Physiol (2007) 5.55
Cell death in cartilage. Osteoarthritis Cartilage (2004) 1.94
Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med (1996) 1.85
Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest (1995) 1.85
Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum (2008) 1.74
Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol (2006) 1.64
Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum (2002) 1.63
Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharmacol (2008) 1.48
Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage. J Neurosci (2008) 1.37
Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum (2003) 1.33
The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med (2009) 1.30
Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum (2000) 1.27
Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol (1998) 1.26
Caspase-dependent and -independent cell death pathways after DNA damage (Review). Oncol Rep (2005) 1.24
Pathobiology of osteoarthritis: pathomechanisms and potential therapeutic targets. Curr Drug Targets (2007) 1.18
Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol (2000) 1.17
Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann Rheum Dis (2005) 1.16
The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J (2007) 1.14
Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes. J Cell Biochem (2007) 1.13
Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res Ther (2005) 1.07
The inducible production of nitric oxide by articular cell types. Osteoarthritis Cartilage (1994) 1.07
Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J (2004) 1.06
Inflammation in osteoarthritis. J Rheumatol Suppl (2004) 1.04
Nitric oxide regulates mitochondrial respiration and functions of articular chondrocytes. Arthritis Rheum (2001) 0.99
The role of nitric oxide in osteoarthritis. Scand J Rheumatol (2007) 0.99
Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann Rheum Dis (2010) 0.99
Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectr (2009) 0.98
Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum (1997) 0.97
Nitric oxide and its role in orthopaedic disease. Clin Orthop Relat Res (1995) 0.90
Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation. J Rheumatol (2002) 0.89
Mitochondria potential, bax "activation," and programmed cell death. Methods Mol Biol (2008) 0.89
Constitutive NADPH oxidase and increased mitochondrial respiratory chain activity regulate chemokine gene expression. Am J Physiol Lung Cell Mol Physiol (2007) 0.89
Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin Chim Acta (2006) 0.87
Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: Pharmacological dissection of iNOS' role in disease. Nitric Oxide (2008) 0.87
Apoptosis induced by nitric oxide is associated with nuclear p53 protein expression in cultured osteoarthritic synoviocytes. Osteoarthritis Cartilage (1999) 0.83
Nitrite and nitrotyrosine concentrations in articular cartilage, subchondral bone, and trabecular bone of normal juvenile, normal adult, and osteoarthritic adult equine metacarpophalangeal joints. J Rheumatol (2006) 0.81
Nitric oxide modifies glycolytic pathways in cultured human synoviocytes. Cell Biol Int (2000) 0.80
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain (2007) 3.35
Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum (2010) 2.43
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Res (2006) 2.38
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology (2003) 2.38
Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature (2008) 2.37
Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease. Nucleic Acids Res (2009) 2.14
Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets. J Mol Biol (2005) 2.04
Mitochondrial complex I plays an essential role in human respirasome assembly. Cell Metab (2012) 2.02
Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood (2011) 1.98
Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann Rheum Dis (2011) 1.78
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Blood (2009) 1.76
Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum (2008) 1.74
Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics (2008) 1.66
Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet (2008) 1.56
Autophagy activation and protection from mitochondrial dysfunction in human chondrocytes. Arthritis Rheumatol (2015) 1.54
X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol (2007) 1.53
Strenuous endurance exercise improves life expectancy: it's in our genes. Br J Sports Med (2010) 1.53
Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther (2009) 1.52
Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry (2012) 1.50
Mechanical injury suppresses autophagy regulators and pharmacologic activation of autophagy results in chondroprotection. Arthritis Rheum (2011) 1.38
Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.37
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther (2009) 1.35
Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum (2003) 1.33
Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics (2008) 1.27
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum (2010) 1.24
Molecular basis of histone H3K4me3 recognition by ING4. J Biol Chem (2008) 1.24
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheum (2009) 1.23
Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics (2005) 1.20
Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus. Nucleic Acids Res (2010) 1.19
Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum (2008) 1.19
Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis (2013) 1.18
Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord (2012) 1.17
Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res (2006) 1.17
Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol (2006) 1.17
Homing endonucleases: from basics to therapeutic applications. Cell Mol Life Sci (2010) 1.16
Folding and aggregation kinetics of a beta-hairpin. Biochemistry (2006) 1.14
Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J Proteomics (2012) 1.14
Renal pathology in children with mitochondrial diseases. Pediatr Nephrol (2005) 1.11
Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4. FEBS Lett (2006) 1.10
Mitochondrial DNA haplogroups do not play a role in the variable phenotypic presentation of the A3243G mutation. Am J Hum Genet (2003) 1.09
Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood (2012) 1.08
Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? J Appl Physiol (1985) (2005) 1.07
Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae. Cardiovasc Res (2007) 1.07
Transcriptome analysis reveals specific changes in osteoarthritis synovial fibroblasts. Ann Rheum Dis (2011) 1.07
Differentiation of synovial CD-105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J Cell Biochem (2009) 1.06
McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol (2008) 1.06
Mitochondrial respiratory chain dysfunction: implications in neurodegeneration. Free Radic Biol Med (2012) 1.04
Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med (2007) 1.03
Structural and functional insights into endoglin ligand recognition and binding. PLoS One (2012) 1.02
In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. PLoS One (2009) 1.02
A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics (2011) 1.01
Crystal structure of I-DmoI in complex with its target DNA provides new insights into meganuclease engineering. Proc Natl Acad Sci U S A (2008) 1.01
Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev (2010) 1.01
ICAM-1 peptide inhibitors of T-cell adhesion bind to the allosteric site of LFA-1. An NMR characterization. Chem Biol Drug Des (2007) 1.01
Whole-exome sequencing identifies a variant of the mitochondrial MT-ND1 gene associated with epileptic encephalopathy: west syndrome evolving to Lennox-Gastaut syndrome. Hum Mutat (2013) 1.00
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol (2014) 1.00
Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res (2011) 1.00
The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia. Arthritis Rheum (2010) 0.99
Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action. Curr Pharm Des (2008) 0.98
World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med (2008) 0.97
Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum (2012) 0.96
Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther (2010) 0.95
Cellular pathophysiological consequences of BCS1L mutations in mitochondrial complex III enzyme deficiency. Hum Mutat (2010) 0.95
A novel cell binding site in the coiled-coil domain of laminin involved in capillary morphogenesis. EMBO J (2003) 0.94
Constraints on protein structure in HIV-1 Rev and Rev-RNA supramolecular assemblies from two-dimensional solid state nuclear magnetic resonance. Biochemistry (2007) 0.94
Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem (2010) 0.94
Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor alpha and interleukin-1beta. Arthritis Rheum (2010) 0.93
Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation (2011) 0.93
Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem Cell Res (2013) 0.93
Leigh syndrome associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFS1 gene. Arch Neurol (2005) 0.93
Strategies to optimize two-dimensional gel electrophoresis analysis of the human joint proteome. Talanta (2009) 0.92
Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events. Int J Cancer (2006) 0.92
The C-terminal RNA binding motif of HuR is a multi-functional domain leading to HuR oligomerization and binding to U-rich RNA targets. RNA Biol (2014) 0.91
Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells. Mol Cell Proteomics (2011) 0.91
Generation and characterization of monospecific and bispecific hexavalent trimerbodies. MAbs (2012) 0.91
Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA. J Rheumatol (2009) 0.90
Hypoxia conditions differentially modulate human normal and osteoarthritic chondrocyte proteomes. J Proteome Res (2010) 0.90
Generation and analysis of mesophilic variants of the thermostable archaeal I-DmoI homing endonuclease. J Biol Chem (2007) 0.90
Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease. Neurochem Res (2006) 0.90
Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS One (2012) 0.90
Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study. Arthritis Res Ther (2012) 0.89
A new mutation in the gene encoding mitochondrial seryl-tRNA synthetase as a cause of HUPRA syndrome. BMC Nephrol (2013) 0.89
Reduced stability and increased dynamics in the human proliferating cell nuclear antigen (PCNA) relative to the yeast homolog. PLoS One (2011) 0.89
Proliferating cell nuclear antigen structure and interactions: too many partners for one dancer? Adv Protein Chem Struct Biol (2013) 0.89
Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain. J Biol Chem (2007) 0.89
Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia. BMC Med Genet (2008) 0.89
Xeno-implantation of pig chondrocytes into rabbit to treat localized articular cartilage defects: an animal model. Wound Repair Regen (2004) 0.89
Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation (2012) 0.89
5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis (2011) 0.89
Influence of the IL6 gene in susceptibility to systemic sclerosis. J Rheumatol (2012) 0.88
Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1. BMC Mol Biol (2010) 0.88